These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1204832)

  • 1. [Experimental research on the hyperprothrombinemic activity of an isocoumarin derivative: antagonism against anticoagulant dicoumarol (Warfarin)].
    Reina RA
    Farmaco Sci; 1975 Dec; 30(12):947-54. PubMed ID: 1204832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the antagonistic effect of an isocoumarin derivative (allyl amide of 4-phenyl-3-isocoumarinic acid) on the anticoagulant activity of 3(alpha-acetonyl-benzyl)-4-hydroxyoumarin].
    Arrigo Reina R; Scoto GM
    Boll Soc Ital Biol Sper; 1974 Aug; 50(15):1207-11. PubMed ID: 4458705
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of 4-phenyl-3-isocoumarinic acid and some of its derivatives on blood coagulation].
    Arrigo Reina R; Scoto GM
    Farmaco Sci; 1973 Jun; 28(6):478-84. PubMed ID: 4716498
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.
    Cepeláková H; Roubal Z; Grimová J; Dlabac A; Cepelák V
    Acta Univ Carol Med Monogr; 1972; 52():55-60. PubMed ID: 4669827
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anticoagulant action of a new synthetic derivative of 4-hydroxycoumarin and antagonism by synthetic vitamin K1 in the rat].
    Thonnart N; Letist D; Reuse JJ
    C R Seances Soc Biol Fil; 1973; 167(6):1081-5. PubMed ID: 4803162
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant activity of Heraclenin.
    Mishra KC; Sharma RC; Sharma YN; Arora RB
    Indian J Physiol Pharmacol; 1969 Jul; 13(3):153-5. PubMed ID: 5362630
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of rats with the Pelargonium sidoides extract EPs 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin.
    Koch E; Biber A
    Phytomedicine; 2007; 14 Suppl 6():40-5. PubMed ID: 17188479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
    Danis O; Yuce-Dursun B; Gunduz C; Ogan A; Sener G; Bulut M; Yarat A
    Arzneimittelforschung; 2010; 60(10):617-20. PubMed ID: 21125812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin antagonism of natto and increase in serum vitamin K by intake of natto.
    Kudo T
    Artery; 1990; 17(4):189-201. PubMed ID: 2360879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on 4-hydroxy-I-thiacoumarins: VI--anticoagulant activity and chemical structure in 4-hydroxy-I-thiacoumarins and related compounds.
    Jamkhandi PS; Rajagopal S; Sirsi M
    Indian J Exp Biol; 1968 Oct; 6(4):224-6. PubMed ID: 5720680
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives.
    Abdelhafez OM; Amin KM; Batran RZ; Maher TJ; Nada SA; Sethumadhavan S
    Bioorg Med Chem; 2010 May; 18(10):3371-8. PubMed ID: 20435480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of Yoshida sarcoma, -aminocaproic acid and sintrom on the blood clotting system in rats.
    Kotschy M; Grzebieluch M; Szacki J; Lawiñski M
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):515-22. PubMed ID: 5095070
    [No Abstract]   [Full Text] [Related]  

  • 14. Coumarin derivatives from Ainsliaea fragrans and their anticoagulant activity.
    Lei L; Xue YB; Liu Z; Peng SS; He Y; Zhang Y; Fang R; Wang JP; Luo ZW; Yao GM; Zhang JW; Zhang G; Song HP; Zhang YH
    Sci Rep; 2015 Aug; 5():13544. PubMed ID: 26315062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant activities of some 2-acyl-1, 3-indandiones.
    Bond HW; Dedhiya MG; Carlson GP
    Arch Int Pharmacodyn Ther; 1973 Jun; 203(2):288-91. PubMed ID: 4800265
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1.
    Shetty HG; Backhouse G; Bentley DP; Routledge PA
    Thromb Haemost; 1992 Jan; 67(1):13-5. PubMed ID: 1615468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in the anticoagulant activities of aflatoxin B 1 and 4-hydroxycoumarin.
    Bababunmi EA; Bassir O
    Afr J Med Sci; 1972 Apr; 3(2):97-103. PubMed ID: 4623912
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of long-term anticoagulant therapy on antithrombin activity.
    Kenedi I; Dózsán G; Péter M
    Ther Hung; 1965; 13(2):57-8. PubMed ID: 5844088
    [No Abstract]   [Full Text] [Related]  

  • 19. Antidotal effect of vitamin K1 against warfarin-induced anticoagulation in horses.
    Byars TD; Greene CE; Kemp DT
    Am J Vet Res; 1986 Oct; 47(10):2309-12. PubMed ID: 3777660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel 3-carboxamide-benzocoumarin derivatives as orally active antithrombotic agents.
    Sashidhara KV; Kumar A; Kumar M; Singh S; Jain M; Dikshit M
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7034-40. PubMed ID: 22004722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.